Thymic T cell anergy, as manifested by thymocyte proliferative unresponsiveness to antigens expressed in the thymic environment, is commonly believed to mediate the acquisition of immunological self-tolerance. However, we previously found that thymic T cell anergy may lead to the breakdown of tolerance and predispose to autoimmunity in nonobese diabetic (NOD) mice. Here, we show that NOD thymic T cell anergy, as revealed by proliferative unresponsiveness in vitro after stimulation through the T cell receptor (TCR), is associated with defective TCRmediated signal transduction along the PKC/p21~'qp42m~p k pathway of T cell activation. PKC activity is reduced in NOD thymocytes. Activation of p21 ~' * is deficient in quiescent and stimulated NOD T cells, and this is correlated with a significant reduction in the tyrosine phosphorylation of p42maP k, a serine/threonine kinase active downstream of p21 ~'s. Treatment of NOD T cells with a phorbol ester not only enhances their p21 r~s activity and p42m~p k tyrosine phosphorylation but also restores their proliferative responsiveness. Since p42m'p k activity is required for progression through to S phase of the cell cycle, our data suggest that reduced tyrosine phosphorylation of p42m'v k in stimulated NOD T cells may abrogate its activity and elicit the proliferative unresponsiveness of these cells.
Summary
Thymic T cell anergy, as manifested by thymocyte proliferative unresponsiveness to antigens expressed in the thymic environment, is commonly believed to mediate the acquisition of immunological self-tolerance. However, we previously found that thymic T cell anergy may lead to the breakdown of tolerance and predispose to autoimmunity in nonobese diabetic (NOD) mice. Here, we show that NOD thymic T cell anergy, as revealed by proliferative unresponsiveness in vitro after stimulation through the T cell receptor (TCR), is associated with defective TCRmediated signal transduction along the PKC/p21~'qp42m~p k pathway of T cell activation. PKC activity is reduced in NOD thymocytes. Activation of p21 ~' * is deficient in quiescent and stimulated NOD T cells, and this is correlated with a significant reduction in the tyrosine phosphorylation of p42maP k, a serine/threonine kinase active downstream of p21 ~'s. Treatment of NOD T cells with a phorbol ester not only enhances their p21 r~s activity and p42m~p k tyrosine phosphorylation but also restores their proliferative responsiveness. Since p42m'p k activity is required for progression through to S phase of the cell cycle, our data suggest that reduced tyrosine phosphorylation of p42m'v k in stimulated NOD T cells may abrogate its activity and elicit the proliferative unresponsiveness of these cells.
F
unctional inactivation or anergy of a T cell is manifested by a long-lasting proliferative unresponsiveness, and may occur as a consequence of an interaction between an Ag or mitogen with the CD3-TCR complex in the absence of a second non-Ag-specific costimulator signal provided by an APC (1). T cell anergy in the thymus and/or periphery generally results in immunological self-tolerance (2-4). In contrast, we have found that beginning at the time of insulitis (7 wk of age), mature CD4 * 8-and CD4-8 + thymic T cells from prediabetic NOD mice are anergic as assessed by stimulation of proliferation in vitro after TCR cross-linking with either an anti-TCR mAb, anti-CD3 mAb, or Con A. This anergy is not due to the inability of thymic APCs to provide costimulation (5, 6, and Rapoport, M., A. Jaramillo, D. Zipris, A. Lazarus, D. Serreze, E. Leiter, P. Cyopick, and T. Delovitch, manuscript submitted for publication), but rather arises predominantly from the inability of these NOD thymic T cells to be stimulated to produce sufficient amounts of IL-4 to support their proliferation (6, and Rapoport, M., et al., manuscript submitted for publication). IL-4 completely reverses this thymic T cell anergy in vitro and when administered in vivo, prevents the onset of diabetes in NOD mice (Rapoport, M. et al., manuscript submitted for publication). These studies raise the possibility that thymic T cell anergy might influence susceptibility to diabetes in NOD mice. Elucidation of the biochemical mechanisms of this NOD thymic T cell anergy may further unravel the basis of the polygenic control of susceptibility to type I diabetes.
In many types of cells, interactions between membrane receptors and a variety of growth factors leads to the activation of the protooncogene p21 ras and subsequent cell proliferation (7) (8) (9) (10) . Stimulation of T cell proliferation through the TCR very rapidly activates p21 ~as by converting its inactive GDP-bound form to its active GTP-bound form (11) . Previously, we observed that stimulation of NOD thymic T cells with phorbol esters (e.g,, phorbol 12-myristate 13-acetate, PMA) restores their proliferative responsiveness upon cross-linking of their TCR (5). Since phorbol ester-induced activation of protein kinase C (PKC) augments p21 ras activity in T cells (11), we examined whether deficient activation of the p21 r~s pathway mediates the proliferative unresponsiveness of NOD thymic T cells. This report provides evidence in support of this notion by demonstrating deficient p21 ~ activation and p42m~v k tyrosine phosphorylation in stimulated NOD thymic T cells, and reversal of these defects by treatment with PMA.
control preimmune rabbit serum and protein A-Sepharose (Pharmacia LKB Biotechnology Inc., Piscataway, NJ). GAP activity in these immunoprecipitates was assayed, as described (16) . GAP activity in nonactivated T cells (calculated as p21~-bound basal cpm) -(p21~-bound cpm in nonactivated cells) was taken to represent maximal (100%) GAP activity. The relative GAP activity in activated T ceils was calculated as follows: 100% x [(p21"s-bound basal cpm)-(p21ra%ound cpm in activated cells)/(p21r~%ound basal cpm)-(p21~-bound cpm in nonactivated cells)].
PKC Assay. Thymocytes (2 x 107/ml) were washed in PBS and lysed by sonication. Intact cells were removed by low speed centrifugation, and the lysates were analyzed for their PKC activity measuring 32p incorporation into histone H1, as described (18) .
Western Blots. Quiescent or activated T cells (107) were resuspended in suspension buffer (150 ram NaC1, 500 #M Na3VO4, 50/~M ZnC12, 2 mM EDTA, 2 mM PMSF, 50 mM Hepes, pH 7.2), and then boiled for 10 rain in SDS sample buffer (16) . Proteins were resolved by SDS-PAGE, transferred to nitrocellulose membranes (Schleicher & Schuell, Inc., Keene, NH) and immunoblotted successively with the Py-72 antiphosphotyrosine mouse mAb (1 #g/ml) or a control mouse mAb (1 /~g/ml) for 4 h, rabbit anti-mouse IgG (2/zg/ml, Jackson Immunoresearch Laboratories, Inc.) for 1 h and nSI-labded protein A (1 /zCi/ml, Amersham Corp., Arlington Heights, IL) for 1 h. Membranes were then dried and autoradiographed for 24 h. For detection of p42 mapk, GAP, and PKC, cell samples were processed and immunoblotted with a polyclonal rabbit anti-p42maP k antibody (1 /~g/ml, Upstate Biotechnology, Inc., Lake Placid, NY), polyclonal rabbit anti-GAP antiserum (1:500 dilution), and a pan-reactive rabbit anti-PKC antibody (2/~g/ml, UBI), respectively, or a control rabbit preimmune serum (1:500 dilution).
Results and Discussion
The ability of TCIL cross-linking to activate p21 ras in thymocytes from 8-wk-old BALB/c (H-2 d) and prediabetic NOD (H-2g 7) mice that display high and low proliferative responsiveness (5), respectively, was assessed. Con A induced a four-to fivefold increase in p21 r~s activity in activated BALB/c thymocytes, whereas it failed to induce p21 ~a' activation in NOD thymocytes (Fig. 1 A) . Western blots obtained using the pan-reactive Y13-259 anti-ras mAb showed no significant difference in the amounts of p21 ra~ present in BALB/c and NOD thymocytes (Lazarus, A. H., unpublished data). To examine whether NOD thymic T cell blasts are also characterized by decreased p21 r~ activity, we determined the p21TM activity in NOD and BALB/c Con A activated thymic T cell blasts. The relative amount of GTP-bound p21 r~ in stimulated rested NOD T call blasts was considerably lower than that observed in similarly treated control BALB/c T cell blasts (Fig. 1 B) . Con A stimulates a twoto threefold increase in p21 ~' activity in BALB/c but not NOD spleen T cells (Fig. 1 C) . Thus, deficient p21 ~ activation is an inherent signaling defect that is expressed after stimulation of quiescent NOD thymocytes as well as NOD thymic and peripheral T cell blasts.
Activation of p21 "~' in T cells stimulated via the TCR is regulated by an inhibition of p21 ~' GTPase activity (11, 19, 20) . To examine whether the relatively low amount of GTPbound p21 r~s observed in stimulated NOD T cells results from a decrease in the activity of the associated GTPase ac- 3) and BALB/c (lanes 4-6) thymic T cell blasts were generated by stimulation of thymocytes with Con A for 48 h, maintained in exponential growth for 72 h in the presence of rlL-2 (100 U/ml), and then deprived of II,-2 for 24 h before assay of p21 r~s activity. In this experiment, the relative amount of GTP-bound p21 ~' * was greater in unstimulated NOD thymocytes (lane 2) than in unstimulated BALB/c thymocytes (lane 5). In general, this was not the case as is evident in Fig. 4 A. (Fig. 2 A) . Basal ras.GAP activity was also comparable in both unstimulated N O D and BALB/c thymocytes. Comparable amouts of p120 ras.GAP were present in N O D and BALB/c thymocytes (Fig. 2 B) .
Thus, the relative activities and amounts of ras.GAP were equivalent in activated N O D and BALB/c thymocytes, and a decrease in activity or amount of ras.GAP does not account for reduced GTP-bound p2Y ~' in activated N O D thymocytes. Deficient activation of p21 r~, in N O D T cells is therefore regulated by either another GAP protein, e.g., the NF1 GAP protein (23, 24) or a guanine nucleotide releasing factor(s) (11, 19, 20) .
Stimulation of T cells via the T C R or by phorbol esters (e.g., PMA) results not only in p21 r~' activation but also tyrosine phosphorylation and activation of a family of serine/ 3 and 4) . Proteins derived from thymic NOD and BALB/c T cells were quantitated for the amount of ras.GAP using an anti-GAP antiserum (lanes 2 and 4) or a control rabbit preimmune serum (lanes I and 3), as indicated. threonine protein kinases known as MAP kinases (MAPK) (25) . Two forms of MAPK of Mr 42,000 (termed p42m~v k) and 44,000 (termed p44m~P k) exist. These MAPK participate in the control of the G0-G1 transition of the cell cycle and the passage of cells through either meiosis or mitosis (26) . Active GTP-bound p21 TM is an upstream effector of MAPK activation by various growth factors in many cell types (26 3,  5, 6, 8, 9, 11, and 12) . The Y13-259 anti-p21TM mAb was used for the immunoprecipitation of samples in lanes 3, 6, 9, and 12, and normal rat IgG was used to treat samples in lanes I, 2, 4, 5, 7, 8, I0 , and 11. Thin layer chromatograms of p21~as-bound nucleoddes eluted from unstimulated and stimulated NOD thymocytes (lanes 1-3) and splenic T cells (lanes 4-6) and from unstimulated and stimulated BALB/c thymocytes (lanes 7-9) and splenic T cells (lanes I0-I2) are displayed. (B) PMA stimulates tyrosine phosphorylation of p42m~# and p44m~p k in NOD T cells. BALB/c (lanes 1 and 3) and NOD (lanes 2 and 4) quiescent thymocytes were either not activated (lanes 1 and 2) or activated (lanes 3 and 4) by PMA for 5 min at 37~ lysed, and analyzed by Western blot analysis with the Py-72 antiphosphotyrosine mAb, as indicated.
for its activity (25) . Anti-CD3 induced substantially less tyrosine phosphorylation of a 42-kD protein in NOD thymocytes in comparison to BALB/c thymocytes (Fig. 3 A) . A lesser increase in the induced tyrosine phosphorylation of a 44-45-kD protein was also observed in activated NOD vs. BALB/c thymocytes. Similar results were obtained with NOD and BALB/c restimulated thymic T cell blasts. Reactivity with a polyclonal rabbit anti-MAPK antibody identified the 42-and 44-45-kD proteins to be p42map k and p44m~P k, respectively, and to be present in similar amount in activated NOD and BALB/c thymocytes (Fig. 3 B) . These findings suggest that a defect in TCR,-mediated activation of p21TM may result in reduced tyrosine phosphorylation and activation of p42m~P k and p44m~P k, which subsequently may inhibit the progression through cell cycle and proliferation of NOD thymocytes.
Direct activation of PKC by PMA in combination with either the calcium ionophore ionomycin or Con A corrects the proliferative defect of NOD thymocytes (5). PMA-induced activation of PKC also augments p21TM activity in T cells (11) . We therefore examined whether activation of PKC by PMA is able to overcome deficient p21TM activation in stimulated NOD thymic T cells. PMA elicited similar levels of p21 r~s activation in NOD and BALB/c thymocytes and splenic T cells (Fig. 4 A) . Tyrosine phosphorylation of p42m~P k and p44m~P ~ is also comparable in both NOD and BALB/c PMA stimulated quiescent thymocytes (Fig. 4 B) . Thus, PMA stimulation of PKC results in normal p21TM activation and p42m~P k and p44map k tyrosine phosphorylation.
Two distinct signaling pathways activated through the TCR, a PKC-dependent and a non-PKC-dependent pathway, regulate p21TM activity in T cells (19, 20) . Our previous observations (5, and Rapoport, M. et al., manuscript submitted for publication) that the basal levels of expression of many cell surface molecules, including the TCR, CD3, CD4, CDS, and the Ib2R are comparable in NOD and BALB/c thymic T cells, raised the possibility that basal levels of activity of certain signal transduction intermediates, such as PKC, may differ between T cells from these two mouse strains. PKC activation is required for the PKC-dependent pathway of p21 TM activation (11) . To examine whether the low p21 r~S activity in NOD T cells may be linked to decreased levels of PKC activity, we measured the basal levels of PKC enzymatic activity in vitro in NOD and BALB/c thymic T cell lysates. The basal activity of PKC in quiescent NOD thymocytes was reduced about twofold compared with that observed in control BALB/c thymocytes (Figs. 5, A and B) . Comparable amounts of PKC protein were detected by a polyclonal rabbit anti-mouse PKC antibody that recognizes all PKC isoforms in Western blots of NOD and BALB/c thymocytes (Fig. 5 C) . Conceivably, the deficient basal PKC activity in NOD thymic T cells may give rise via the PKC-dependent pathway to decreased p21TM activity in these T cells.
Thus, NOD thymic and peripheral T cell anergy may result from a defect(s) along the PKC/p21=s/p42mav k pathway of T cell activation. This possibility is supported by our findings presented here that: (a) PKC activity is reduced in NOD thymocytes; (b) p21TM activation is deficient in quiescent and stimulated N O D T cells; (c) a direct link exists between p21 r's and MAPK activation in T cells; (d) the level of tyrosine phosphorylation of p42m~P k is diminished in activated NOD T cells; (e) PMA corrects the proliferative defect of NOD T cells; and ~ PMA enhances both p21TM activity and MAPK tyrosine phosphorylation in activated NOD T cells. Since MAPK activity is required for gene activation, progression through the cell cycle and cell proliferation, reduced tyrosine phosphorylation of p42m~v k in stimulated NOD T cells likely abrogates its activity and elicits the proliferative unresponsiveness of these cells.
Peripheral T cell anergy has been documented both in NOD mice (5, 27, 28) and in prediabetic patients (29) , and in the latter case has been implicated as an indicator of progression to overt disease. Our observation that p21 r's activation is deficient in stimulated NOD peripheral T cells therefore raises the possibility that analysis of p21 =' activity in human peripheral blood T cells may be used to detect diabetes onset in prediabetic individuals at high risk. It also remains to be determined whether our findings of decreased p21 r'~ activity are restricted to anergic prediabetic NOD T cells or can also be applied to anergic T cells in other autoimmune diseases. The latter scenario would provide additional support for the possibility raised herein that an important association exists between a defect(s) in TCR-linked signal transduction and susceptibility to T cell-mediated autoimmune disease.
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